Genscript Biotech Corporation
OTC: GNNSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Weihui Shao
- Employees
- 5,568
- Headquarters
- Nanjing, China
- IPO year
- 2017
- Market cap
- $3.5B
- Website
- https://www.genscript.com
Loading GNNSF…
Loading profile data…Frequently asked questions about GNNSF
What does Genscript Biotech Corporation (GNNSF) do?
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan, other Asia Pacific regions, and beyond. The company is structured into four distinct business units. Its Life Science Services and Products divisi...
Where does GNNSF trade?
Genscript Biotech Corporation (GNNSF) trades on the Other OTC.
What sector is GNNSF in?
Genscript Biotech Corporation (GNNSF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Genscript Biotech Corporation?
Weihui Shao is the chief executive officer of Genscript Biotech Corporation (GNNSF).
Where is Genscript Biotech Corporation headquartered?
Genscript Biotech Corporation is headquartered in China.
Does GNNSF pay a dividend?
Genscript Biotech Corporation (GNNSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNNSF go public?
Genscript Biotech Corporation (GNNSF) completed its initial public offering in 2017.